REDUCE ALZHEIMER’S DISEASE RISK BY AVOIDING BRAIN ISCHEMIA WITH VEIN LITE, OXYPOWER, ASPARAGUS EXTRACT, WINE EXTRACT, METAL FLUSH
Omega-3 fish Oils Have No Effect on Cognitive Function
|
| CHI HEALTH LETTER |
September 4, 2015 |
|
A study published just this August found that taking Omega-3 fish oils does not have any effect at all on cognitive function. Many people take the Omega-3 fatty acids, EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid), to improve memory; however, this new study will change that practice. The study involved almost 4,000 older men and women (average age is 73) with age-related macular degeneration, considered one of the risk factors of cognitive decline. Results showed that supplementation with EPA/DHA or lutein/zeaxanthin did not stop cognitive decline at all (JAMA. Aug 2015;314(8):791-801).
Vein Lite is a much better supplement as it reduces amyloid beta deposits (Source: Chinese Journal of Ethnomedicine & Ethnopharmacy. 2009:9-10), which is one of the hallmarks of Alzheimer’s disease and improves cardiovascular function. There is much evidence linking cardiovascular health to brain function, as we see in these cases. |
Featured Stories
CASE 1:
Heart Bypass Surgeries, Brain Atrophy, Short-Term Memory Loss
T. Callaghan, MD from MS, has a 74-year-old male patient who has had 3 bypasses. He now has short-term memory loss, brain atrophy and balance issues when walking. He presents with a red lunula on the thumb, a sign of heart disease (Figure 1).
CASE 2: Hypertension, Heavy Metal Toxicity, Severe Memory Loss
F.F. is an 80-year-old female from Florida who has an ear crease (Figure 2) and dark, protruding veins under the tongue (Figure 3). As you have learned from our past newsletters, an ear crease signals heart disease. Dark protruding veins under the tongue signal heavy metal toxicity. She reveals that she does have hypertension, heavy metal toxicity and now has severe memory loss.
Having these markers should already alert you to at least a risk for heart problems. Heavy metal toxicity, too, can lead to heart problems. Both of these affect the brain and cognitive function. As in the cases above, one has hypertension and heavy metal toxicity which affected her memory. The other one had heart problems (3 bypass surgeries) that also affected his brain and he developed Alzheimer’s disease. |
Heart Disease Linked to Alzheimer's Disease Risk
Back in 2010, Alzheimer’s disease (AD) was already the 2nd most feared disease next to cancer in a survey on 1,007 American adults. In 2015, people worry about Alzheimer’s disease almost as much as cancer (Source: Metlife Foundation). This worry is not unfounded. In the United States alone, there are more than 5 million people with Alzheimer’s disease (AD) with one new case every 67 seconds. One in 10 adults over 65 years old are diagnosed with AD. Among those over 80 years old, 30% have AD symptoms: memory loss, lack of the sense of direction and time, language impediments, confusion, and so on. Once diagnosed, the progression of AD can cause organ failure and eventually death. With more and more people living beyond 90 years old, many fear developing Alzheimer’s disease as it means you lose your dignity and are totally dependent on others.
AD drugs that are available on the market target acetylcholine, which is low in AD and causes loss of memory and cognitive functions in AD patients. But the question is do you really want to wait until you develop AD before addressing it? Wouldn’t it be better if you can reduce your risk for developing AD and perhaps avoid it altogether?
In the past, degeneration of brain cells (neurons) seen in AD was considered to be because of aging alone; however, new and emerging studies have seen that AD and cardiovascular disease (CVD) share many characteristics and triggers. This led to the conclusion that addressing cardiovascular issues can significantly reduce the risk of AD.
We have seen that in the featured cases today. In Case 1, the patient has a history of heart disease, undergoing 3 bypass surgeries. Now he has brain atrophy and memory problems. In Case 2, the patient has an ear crease (sign of CVD), hypertension and heavy metal toxicity (which can affect cardiovascular function). Now she has severe memory loss.
So using early markers of CVD can also alert you to a possible risk for AD. Later on we will see how CVD can affect brain and cognitive function.
|
Signs of Alzheimer's Disease
In addition to CVD markers, the following are also early signs of AD.
- Ear ringing - If you have ear ringing but have no hypertension or sinus problems, this may signal hardening of the arteries (atherosclerosis) especially near the brain.
- Balance issues – If you easily lose your balance (falls down easily), this may also be a sign of early AD
- Short-term memory loss – Many AD patients first experience sporadic memory loss. For example, they can’t remember where they left their keys. As AD gets worse, they may eventually not recognize their own family members.
- No sense of direction or time – In later stages of AD, patients often get confused as to what time it is or their location.
- Language/Speech issues – Because of damage to the hippocampus, AD patients may start to have difficulty recognizing words and may become confused. Due to this, they may lack the desire to read and also have trouble articulating words
|
Hypoxia and Ischemia Increases Amyloid beta deposits, Lowers Acetylcholine, Causes Oxidative Damage to Neurons
There is quite a number of evidence to suggest that the lack of blood flow to the brain (cerebral ischemic episodes) may be the trigger that causes loss of neurons and initiates the cognitive changes seen in Alzheimer’s disease (Figure 4). The hypoxic condition (lack of oxygen) caused by ischemia leads to increased amyloid beta production and plaque formation in central neurons. Hypoxia also leads to oxidative stress that causes damage to neurons. Brain autopsies of Alzheimer’s patients discovered substantial oxidative damage caused by free radicals (Sources:
Molecular Neurobiology. 2013; 48:500-515;
Ann NY Acad Sci. 2005; 1043:545-52).
 |
|
This mechanism is much like what happens in a cerebral stroke. The lack of blood flow causes damage to the hippocampus, making it difficult to remember things and recognize words and people, which are some of the characteristics of AD. This damage can eventually spread to other areas of the brain as AD progresses. This can sometimes take 8-10 years. People who have had an aneurysm, brain stenosis, or stroke are therefore at high risk for brain atrophy and AD. Figure 5A illustrates a healthy brain while Figure 5B shows what brain atrophy caused by ischemia (hollow areas) looks like in an AD patient.
Short-term memory loss in AD patients is due to low levels of the neurotransmitter, acetylcholine. Studies show that hypoxia due to ischemia can cause lower levels of acetylcholine.
As you recall from our last three issues of the Chi Health Letter, we have pointed that that cherry angiomas on the forehead can be a sign of aneurysm or stroke risk. So if you have these, you need to address your CVD risk in order to reduce your risk for developing AD.
One way of addressing ischemia and, consequently, hypoxia is by reducing inflammation. To check for inflammation, find out your C-reactive protein (CRP) level. Ideally, CRP should be under 1.0. An elevated CRP, especially if it is over 3, already signifies high cardiovascular risk. The higher it is, the greater the chance is for a stroke and, later on, AD.
|
Alzheimer’s Disease Related to 2 Genes that regulate Homocysteine and LDL cholesterol
A recent report from the Mayo Clinic states that AD may also be related to two genes, both of which are related to cardiovascular and coronary heart disease. One gene regulates homocysteine level. Abnormality in this gene can cause high homocysteine (also increases heart disease risk) and lead to low absorption of folate, which is associated with poor memory and cognitive performance.
The other gene makes the LDL (bad cholesterol) high and fat particles small. LDL is highly oxidative and increases the risk for blood clots and stroke.
Vein Lite and Asparagus Extract can help reduce homocysteine while Wine Extract and Vein Lite can reduce LDL.
|
Reduce AD Risk by Improving Cardiovascular Function
To better address AD risk and improve cognitive function, we need to prevent circulation or cardiovascular issues that trigger brain atrophy. Improving blood flow and oxygen as well as reducing inflammation are some of the ways of reducing AD risk. Vein Lite, OxyPower, Asparagus Extract, Metal Flush and Wine Extract are worthwhile supplements to take for AD.
Vein Lite (Reduces Ischemia, Amyloid peptide, CRP/Inflammation and Homocysteine)
In the past August 14, 2015 issue of the Chi Health Letter, we enumerated the different mechanisms of Vein Lite in improving cardiovascular function. For AD, Vein Lite can particularly reduce ischemia and amyloid deposits by increasing blood flow and reducing the risk of blood clots. Additionally, it has been shown to also reduce CRP/inflammation as well as homocysteine levels.
An in vivo experiment was conducted to test Vein Lite’s effect on memory, with or without brain damage. Group A contained older rats with and without brain damage. Group B contained younger rats with and without brain damage. Fifty percent of each group was given Vein Lite in appropriate doses for 30 days and kept separately. All of the rats in both groups were then placed in a maze and results showed that the rats that had taken Vein Lite retained a higher level of memory in both brain damaged and non-brain damaged categories.
A clinical study later confirmed the effect of Vein Lite on cerebral function. Out of 109 patients with cerebral stroke, 56 cases were randomly chosen as the control group while 53 cases received Vein Lite. After 6 months, the Vein Lite group produced greater levels of improvement than the control group. The researchers concluded that Vein Lite can improve cognitive function after a cerebral stroke, as seen in increased brain wave activity through electroencephalogram (EEG) tests.
OxyPower (Reduces CRP/Inflammation and Oxidative Damage)
OxyPower can quickly reduce C-Reactive Protein (CRP) and inflammation. It also increases the heart’s ejection fraction rate, improving blood flow and reducing the risk of ischemia. It is also a powerful antioxidant, reducing free radical damage by reducing the highly oxidative superoxide dismutase while increasing the protective glutathione.
Read more about OxyPower’s cardioprotective functions in our August 7, 2015 Chi Health Letter.
Asparagus Extract (Reduces Homocysteine)
Asparagus Extract is a rich source of natural folate and has been shown to reduce homocysteine level. Furthermore, it is also a natural diuretic and ACE inhibitor. Both of these functions can reduce hypertension, a risk factor for ischemia and stroke.
Wine Extract (Reduces LDL)
Wine Extract is an excellent natural supplement to correct high LDL, increase HDL (good cholesterol) and reduce triglycerides. It also contains over 50% resveratrol. Studies show that resveratrol can greatly benefit brain and heart functions by maintaining heart rhythm, increasing HDL (good) cholesterol, reducing oxidative stress. (Sources:
Mol Nutr Food Res. 2005;49(5): 377-95;
Life Sci. 2003;72(21):2369-79.
Metal Flush Reduces Heavy Metal Toxicity to Improve Cognitive Function
Heavy metals play a role in brain function and AD. People with heavy metal toxicity, especially aluminum, often have brain fog and poor memory, among other symptoms. Metal Flush is a natural, oral chelating supplement that effectively and safely removes lead, mercury, cadmium, arsenic, aluminum, etc.
G. Simonian, DC from CA, has an 80 y/o/f patient with memory loss and dementia. A hair analysis revealed that her aluminum level was high. She took Vein Lite, Metal Flush and used Bathdetox (Table 1).
 |
|
 |
|
Mineral Infrared Therapy (Increases Acetylcholine)
About 90% of Alzheimer’s patients have low acetylcholine levels. The Mineral Infrared Therapy (MIT) machine (Figure 6) can be used to increase this neurotransmitter. One study shows that the MIT increased acetylcholine by 42% in 30 minutes and by 70% in 60 minutes (Table 2). Many people use the MIT to improve brain functions.
|
Case Reports
P.P., a 55‐year‐old female from California, shares with us how Vein Lite has improved her cognitive function: “If I miss my morning dose of Vein Lite, I have a very hard time thinking and concentrating on minor tasks. I’ve sincerely noticed that my speech will slur when I’ve gone a long time without these extracts. Taking these extracts helps circulate the blood throughout my body. I no longer wake up with numbness in my hands and legs. The other day, my boss even mentioned that my performance at work has visibly improved since starting the Chi program.”
A. Sayler, CN from FL, has a 45 y/o/f patient who relates that after two days of taking OxyPower, she felt an increase in energy as well as much improved memory/cognition.
G. Depke, ND from California, has a 67 y/o/f patient with ischemia and high CRP. After taking OxyPower, Vein Lite and Wine Extract for almost 4 months, her CRP and cholesterole levels reduced (Table 3).
W. Smith, DC from CA, has a 55 y/o/f patient who had difficulty concentrating, slurred speech and numbness in the limbs. She relates that taking Vein Lite helps circulate the blood throughout the body. Her focus is much better. She no longer has numbness and slurred speech.
|
SUMMARY
Do not wait until you develop Alzheimer’s disease symptoms before addressing the disease. It is best to reduce your risk for AD or avoid it altogether. To do this, look for early signs of cardiovascular disease because CVD significantly increases your risk for brain ischemia which causes cognitive decline. Look for cherry angiomas on the forehead, earlobe crease, lack of lunulae, etc. (See all four of our August 2015 newsletters for a complete list of CVD markers).
If you do have CVD or have signs of CVD, you can take the following to reduce the risk of brain ischemia and damage to neurons.
|
If you missed old issues of our Chi Health Letter,
you can access them now.
Check out our
ARCHIVES
|
|
ORGANIC GERMANIUM-132 NEW BATCH AND PRICE INCREASE
|
|
We have started distributing our new batch of organic Germanium-132 on august 25, 2015. As announced, the price has increased to $50.00 per bottle of 60 capsules for this new batch.
Please also take note that this new batch will have a different capsule color. It will be red instead of white.
For more information, please contact (714) 777-1542.
|
|
|
|
Please visit our booth at these conventions.
CANCER CONTROL CONVENTION
September 5-7
Sheraton Universal
Hollywood, CA
Booth 13
AARM CONFERENCE
October 1-4
Semiahmoo Resort
Blaine, WA
Booth 208
NEW LIFE EXPO
October 16-18
Hotel Pennsylvania
New York, NY
Booth 320
PACIFIC SYMPOSIUM
Oct 30 - Nov 1
Catamaran Resort Hotel
San Diego, CA
Booth 67
For more information, please contact (714) 777-1542.
|
PATIENT SCREENINGS IN YOUR AREA
|
|
Interested in a Fingernail and Tongue Analysis screening by Dr. Chi himself? He may be in your area. Check out the schedule below.
Brooklyn, NY
October 19-21
Dr. Chi will also be available for private consultations in these areas:
Blain, WA
October 1-3
Las Vegas, NV
December 10-12
Call (714) 777-1542 to make an appointment or for more information
|
CONSULT WITH
DR. CHI
AND START YOUR JOURNEY TO A HEALTHIER YOU
|
Did you know that you can consult with Dr. Chi in person or over the phone?
Call us now at
(714) 777-1542
to book your appointment.
You will be amazed at the results!
For more information,
visit this page.
|
|
CONTACT US
|
|
Chi's Enterprise, Inc.
1435 N. Brasher Street
Anaheim, CA 92807
(714) 777-1542
www.chi-health.com
postmaster@chi-health.com
|
| |
|
|
|
